Synthetic Minds | Brain Implants Just Had Their Biggest Week. You Missed It.
The Synthetic Minds newsletter offers short daily insights to get you thinking. If you enjoy it, please forward. If you need more insights, subscribe to Futurwise and get 25% off for the first three months!
I turned my book into an interactive masterclass, built entirely with AI. Read how I did it here, or start using it for free.
Today’s topic: Health and BCIs
Brain-Computer Interfaces Just Had Their Biggest Week. You Missed It.
Two people with paralysis, one with ALS, one with a spinal cord injury, typed at 22 words per minute using a brain-computer interface. Not in a research hospital. In their homes. Published this week in Nature Neuroscience by the BrainGate team.
That's the clinical story. Here is the signal.
While Neuralink talks high-volume production and human-machine symbiosis, a university team quietly demonstrated what actually matters: a paralyzed person communicating at near-normal speed, reliably, where they live.
The gap between spectacle and utility just closed, on the clinical side, not the commercial one.
China noticed. Beijing's 15th Five-Year Plan elevates BCI to a strategic "industry of the future" alongside quantum and 6G, targeting world-class firms by 2030. This month, China's NMPA granted Neuracle's NEO implant commercial clearance, while Neuralink's device remains in US clinical trials.
More than ten invasive human trials are underway. Pilot provinces already cover BCI treatments under national medical insurance.
The US leads on evidence. China is building state-backed infrastructure to commercialise it. Neither has answered the harder question: who pays for neural interfaces when they outperform every assistive device on the market?
Disability economics were designed for eye-trackers, not cortical keyboards.
The BCI race isn't between Neuralink and its competitors. It's between two governance models, and neither is ready.
'Synthetic Minds' continues to reflect the synthetic forces reshaping our world. Quick, curated insights to feed your quest for a better understanding of our evolving synthetic future, powered by Futurwise:
1. As AI systems become increasingly sophisticated, they are beginning to mimic human-like behavior, including empathy and emotional intelligence, which is a dangerous direction. (Nature)
2. The healthcare industry is embracing AI to improve medical imaging, drug discovery, and other core applications, leading to significant return on investment (ROI) and increased revenue. (NVIDIA)
3. Tickling has long intrigued philosophers and scientists alike. Recent laboratory work using a robotic tickler, Hektor, and neuroimaging techniques offers fresh insights into the neural circuitry, evolutionary roots, and individual variability of this playful sensation today. (Scientific American)
4. The Enhanced Games startup, backed by Peter Thiel and Donald Trump Jr., plans a 2026 Las Vegas event featuring performance‑enhancing peptides. The company will also launch an online health portal selling eight FDA‑banned peptides. (Gizmodo)
5. AI is promoted as a panacea for food systems, yet its deployment raises data ownership, labor displacement, and environmental concerns that threaten food security. (Civil Eats)
If you are interested in more insights, grab my latest, award-winning, book Now What? How to Ride the Tsunami of Change and learn how to embrace a mindset that can deal with exponential change.
If this newsletter was forwarded to you, you can sign up here.
Thank you.
Mark
